Novel Procedure Seals Off Leaks In Patients With Single-Ventricle Heart Disease

Researchers report insights on the novel lymphatic intervention that aids in sealing off the leaks in a rare complication of single-ventricle heart disease.

In patients with single-ventricle heart disease, a novel procedure was done to seal off the leaks from the liver's lymphatic system and the symptoms in patients were also found to be improved, reveal researchers.

The researchers, from //Children's Hospital of Philadelphia and Penn Medicine, focused on protein-losing enteropathy (PLE), a severe loss of proteins in the intestine that is a rare but potentially life-threatening side effect of staged heart surgery in patients with single-ventricle disease.

Stress Remodels Lymphatic System and Promotes Cancer Metastasis
Chronic stress induces stable changes in lymphatic architecture and increases lymphogenic tumor cell dissemination leading to increased lymph node metastasis.

‘The novel lymphatic system imaging and intervention also cures patients with plastic bronchitis and chylothorax.’

The cause of PLE is unknown, but scientists have suspected the lymphatic system was involved. The team's study, published recently in the Journal of the American College of Cardiology, confirms the role of abnormal lymphatic circulation between the liver and small intestine. It also and demonstrates how liver lymphatic imaging and a novel intervention that seals off the abnormal lymph flow can improve the quality of life for patients with this condition.

"We are learning that more and more conditions are caused by leaks in the lymphatic system," said Maxim Itkin, MD, co-author of the study and co-director of the Center for Lymphatic Imaging and Interventions at CHOP and Penn Medicine.

"After identifying the leakage site in a lymphatic vessel, the team intervenes, using a technique called lymphatic embolization. Through a small needle, we can block the abnormal flow with a variety of tools - endovascular glue, coils, iodized oil - based on an individual patient's needs."

Tumor Activated Protein Promotes Metastasis
Researchers report that cancers physically alter cells in the lymphatic system – a network of vessels that transports and stores immune cells throughout the body – to promote the spread of disease, a process called metastasis.

"Patients with devastating side effects of the single-ventricle palliation process, such as protein-losing enteropathy, endure frequent trips to the bathroom, and their bodies lose essential protein. We have long suspected the lymphatic system was involved and can now begin to provide hope for these patients," said Yoav Dori, MD, PhD, co-author of the study and co-director of the Center for Lymphatic Imaging and Interventions at CHOP and Penn Medicine.

The CHOP-Penn Medicine team has previously shown that this novel lymphatic system imaging and intervention can cure patients with plastic bronchitis and chylothorax, two other devastating side effect of single-ventricle palliative surgery. The current study is a retrospective review of imaging and medical records of eight patients with congenital heart disease (CHD) with elevated central venous pressure complicated by PLE who underwent lymphatic imaging and interventions at CHOP. The patients included six children and two adults, with a median age of 21 years.

Cancer Cells In Breast Tissue Predicts Lymph Nodes Could Be Next
Lymphovascular invasion (LVI), the presence of cancer cells in blood vessels or lymphatic system, points to a distinct possibility of cancer recurrence in nearby lymph nodes.

In their analysis, the researchers demonstrated lymphatic congestion within the liver and leakage of the liver lymph into the duodenum, mostly through abnormal lymphatic connections. Their findings strongly suggest that this is the dominant cause of PLE in this cohort, and likely in the CHD population.

The authors said that their promising initial report must be followed by further investigation. "Further research and experience with the technique is needed to improve long-term outcomes of this procedure," they added.

New Nanotech Drug Delivery System Shows Promise for Improved Melanoma Treatment
Researchers have developed a new three-drug delivery system for cancer treatment, especially metastatic melanoma.

Source-Eurekalert